122 related articles for article (PubMed ID: 32165166)
1. microRNA-454 promotes liver tumor-initiating cell expansion by regulating SOCS6.
Lei Z; Tang X; Si A; Yang P; Wang L; Luo T; Guo G; Zhang Q; Cheng Z
Exp Cell Res; 2020 May; 390(1):111955. PubMed ID: 32165166
[TBL] [Abstract][Full Text] [Related]
2. microRNA-29a regulates liver tumor-initiating cells expansion via Bcl-2 pathway.
Song S; Sun K; Dong J; Zhao Y; Liu F; Liu H; Sha Z; Mao J; Ding G; Guo W; Fu Z
Exp Cell Res; 2020 Feb; 387(2):111781. PubMed ID: 31857112
[TBL] [Abstract][Full Text] [Related]
3. miR-96 regulates liver tumor-initiating cells expansion by targeting TP53INP1 and predicts Sorafenib resistance.
Huang Y; Zhang J; Li H; Peng H; Gu M; Wang H
J Cancer; 2020; 11(22):6545-6555. PubMed ID: 33046975
[TBL] [Abstract][Full Text] [Related]
4. miR-552 Regulates Liver Tumor-Initiating Cell Expansion and Sorafenib Resistance.
Han T; Zhang Y; Yang X; Han L; Li H; Chen T; Zheng Z
Mol Ther Nucleic Acids; 2020 Mar; 19():1073-1085. PubMed ID: 32044726
[TBL] [Abstract][Full Text] [Related]
5. miR-124 regulates liver cancer stem cells expansion and sorafenib resistance.
Feng Y; Jiang W; Zhao W; Lu Z; Gu Y; Dong Y
Exp Cell Res; 2020 Sep; 394(2):112162. PubMed ID: 32640195
[TBL] [Abstract][Full Text] [Related]
6. NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma.
Leung HW; Lau EYT; Leung CON; Lei MML; Mok EHK; Ma VWS; Cho WCS; Ng IOL; Yun JP; Cai SH; Yu HJ; Ma S; Lee TKW
Cancer Lett; 2020 Apr; 476():48-56. PubMed ID: 32061952
[TBL] [Abstract][Full Text] [Related]
7. miR-194 inhibits liver cancer stem cell expansion by regulating RAC1 pathway.
Ran RZ; Chen J; Cui LJ; Lin XL; Fan MM; Cong ZZ; Zhang H; Tan WF; Zhang GQ; Zhang YJ
Exp Cell Res; 2019 May; 378(1):66-75. PubMed ID: 30844391
[TBL] [Abstract][Full Text] [Related]
8. miR-93 regulates liver tumor initiating cells expansion and predicts chemotherapeutic response of patients.
Li J; Zhong X; Wang X; Xu F; Yang J; Lu J; Liu C; Lu J
Arch Biochem Biophys; 2021 May; 703():108871. PubMed ID: 33831356
[TBL] [Abstract][Full Text] [Related]
9. Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2.
Wang G; Zhao W; Wang H; Qiu G; Jiang Z; Wei G; Li X
Med Sci Monit; 2019 Sep; 25():7209-7217. PubMed ID: 31553714
[TBL] [Abstract][Full Text] [Related]
10. miR-613 inhibits liver cancer stem cell expansion by regulating SOX9 pathway.
Li B; Liu D; Yang P; Li HY; Wang D
Gene; 2019 Jul; 707():78-85. PubMed ID: 31075412
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways.
Xu Y; Huang J; Ma L; Shan J; Shen J; Yang Z; Liu L; Luo Y; Yao C; Qian C
Cancer Lett; 2016 Feb; 371(2):171-81. PubMed ID: 26655273
[TBL] [Abstract][Full Text] [Related]
12. miR-206 inhibits liver cancer stem cell expansion by regulating EGFR expression.
Liu C; Li J; Wang W; Zhong X; Xu F; Lu J
Cell Cycle; 2020 May; 19(10):1077-1088. PubMed ID: 32286127
[TBL] [Abstract][Full Text] [Related]
13. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.
Karkampouna S; van der Helm D; Gray PC; Chen L; Klima I; Grosjean J; Burgmans MC; Farina-Sarasqueta A; Snaar-Jagalska EB; Stroka DM; Terracciano L; van Hoek B; Schaapherder AF; Osanto S; Thalmann GN; Verspaget HW; Coenraad MJ; Kruithof-de Julio M
J Pathol; 2018 Jul; 245(3):297-310. PubMed ID: 29604056
[TBL] [Abstract][Full Text] [Related]
14. Cyclin G1 expands liver tumor-initiating cells by Sox2 induction via Akt/mTOR signaling.
Wen W; Han T; Chen C; Huang L; Sun W; Wang X; Chen SZ; Xiang DM; Tang L; Cao D; Feng GS; Wu MC; Ding J; Wang HY
Mol Cancer Ther; 2013 Sep; 12(9):1796-804. PubMed ID: 23804702
[TBL] [Abstract][Full Text] [Related]
15. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
[TBL] [Abstract][Full Text] [Related]
16. miR-219 regulates liver cancer stem cell expansion via E-cadherin pathway.
Si A; Wang L; Miao K; Zhang R; Ji H; Lei Z; Cheng Z; Fang X; Hao B
Cell Cycle; 2019 Dec; 18(24):3550-3561. PubMed ID: 31724462
[TBL] [Abstract][Full Text] [Related]
17. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.
Ma S; Tang KH; Chan YP; Lee TK; Kwan PS; Castilho A; Ng I; Man K; Wong N; To KF; Zheng BJ; Lai PB; Lo CM; Chan KW; Guan XY
Cell Stem Cell; 2010 Dec; 7(6):694-707. PubMed ID: 21112564
[TBL] [Abstract][Full Text] [Related]
18. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.
Lai SC; Su YT; Chi CC; Kuo YC; Lee KF; Wu YC; Lan PC; Yang MH; Chang TS; Huang YH
J Exp Clin Cancer Res; 2019 Nov; 38(1):474. PubMed ID: 31771617
[TBL] [Abstract][Full Text] [Related]
19. miR-361-3p Regulates Liver Tumor-initiating Cells Expansion and Chemo-resistance.
Qu S; Zhang X; Wu Y; Li H; Zhai J; Wu D
J Cancer; 2021; 12(5):1483-1492. PubMed ID: 33531993
[TBL] [Abstract][Full Text] [Related]
20. MiR-25 enhances autophagy and promotes sorafenib resistance of hepatocellular carcinoma via targeting FBXW7.
Feng X; Zou B; Nan T; Zheng X; Zheng L; Lan J; Chen W; Yu J
Int J Med Sci; 2022; 19(2):257-266. PubMed ID: 35165511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
